ANDA 90786, held by Wockhardt Ltd. Carbidopa; Entacapone; Levodopa.
As of Nov 16, 2026, ANDA 90786 (Carbidopa, Levodopa And Entacapone), held by Wockhardt Ltd, was first approved by FDA on Nov 20, 2012, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 20, 2012 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbidopa, Levodopa And Entacapone12.5MG;200MG;50MG · tablet;oral | Carbidopa; Entacapone; Levodopa | Discontinued |
| Nov 2, 2014 | Supplement 1Labeling · Standard review | Approved | None posted |
| Nov 20, 2012 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters